Published in Alcohol Clin Exp Res on October 23, 2009
Obesity and the brain: how convincing is the addiction model? Nat Rev Neurosci (2012) 2.26
OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. Drug Alcohol Depend (2010) 1.55
Relapse prevention for addictive behaviors. Subst Abuse Treat Prev Policy (2011) 1.29
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res (2011) 1.18
Is food addiction a valid and useful concept? Obes Rev (2012) 1.14
Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcohol Clin Exp Res (2012) 1.12
The genetics of the opioid system and specific drug addictions. Hum Genet (2012) 1.04
Neurotransmitter and neuromodulator genes associated with a history of depressive symptoms in individuals with alcohol dependence. Alcohol Clin Exp Res (2010) 0.91
Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents. Alcohol Clin Exp Res (2012) 0.88
Genetic influences on adolescent behavior. Neurosci Biobehav Rev (2016) 0.88
COMT and ALDH2 polymorphisms moderate associations of implicit drinking motives with alcohol use. Addict Biol (2011) 0.87
Evaluating a cognitive model of ALDH2 and drinking behavior. Alcohol Clin Exp Res (2010) 0.86
Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults. Addict Biol (2014) 0.86
Pharmacogenetics of OPRM1. Pharmacol Biochem Behav (2013) 0.81
μ-Opioid receptor gene (OPRM1) polymorphism A118G: lack of association in Finnish populations with alcohol dependence or alcohol consumption. Alcohol Alcohol (2013) 0.81
The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects. J Clin Pharmacol (2013) 0.77
A psycho-genetic study of hedonic responsiveness in relation to "food addiction". Nutrients (2014) 0.77
Neurobiology of adolescent substance use and addictive behaviors: treatment implications. Adolesc Med State Art Rev (2014) 0.76
The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol (1986) 124.55
Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry (1997) 41.93
The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry (2003) 21.70
Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics (1992) 21.26
Towards the assessment of adolescent problem drinking. J Stud Alcohol (1989) 14.10
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry (2008) 4.91
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
Genetic structure, self-identified race/ethnicity, and confounding in case-control association studies. Am J Hum Genet (2004) 4.51
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66
Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry (1994) 3.64
Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav (2007) 3.60
Genetic and environmental influences on alcohol, caffeine, cannabis, and nicotine use from early adolescence to middle adulthood. Arch Gen Psychiatry (2008) 3.57
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem (2005) 3.53
Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol (1998) 3.07
An 8-year follow-up of 450 sons of alcoholic and control subjects. Arch Gen Psychiatry (1996) 3.02
Item response theory analysis of diagnostic criteria for alcohol and cannabis use disorders in adolescents: implications for DSM-V. J Abnorm Psychol (2006) 2.92
Population stratification in the candidate gene study: fatal threat or red herring? Psychol Bull (2004) 2.81
Alcohol challenge with sons of alcoholics: a critical review and analysis. Psychol Bull (1990) 2.73
DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behav Genet (1997) 2.64
Acute effects of ethanol on social behavior of adolescent and adult rats: role of familiarity of the test situation. Alcohol Clin Exp Res (2002) 2.53
Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry (2007) 2.28
A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res (2004) 2.25
Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. Environ Health Perspect (1999) 2.21
Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem (2004) 2.07
Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet B Neuropsychiatr Genet (2003) 2.07
Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend (2006) 1.96
Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet (2006) 1.93
Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res (2007) 1.86
Four-year outcomes from adolescent alcohol and drug treatment. J Stud Alcohol (2001) 1.86
Self-reported race and genetic admixture. N Engl J Med (2006) 1.85
Neurobiology of addiction: treatment and public policy ramifications. Nat Neurosci (2005) 1.75
Genetic and environmental influences on stages of alcohol use across adolescence and into young adulthood. Behav Genet (2006) 1.74
Using dimensional models of externalizing psychopathology to aid in gene identification. Arch Gen Psychiatry (2008) 1.73
Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol Psychiatry (1998) 1.72
Adolescents are not adults: developmental considerations in alcohol users. Alcohol Clin Exp Res (2000) 1.69
Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology (2005) 1.66
Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry (1999) 1.66
A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling. J Biol Chem (2000) 1.65
Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci (2002) 1.62
Pharmacogenetics of opioids. Clin Pharmacol Ther (2007) 1.59
Differences in the social consequences of ethanol emerge during the course of adolescence in rats: social facilitation, social inhibition, and anxiolysis. Dev Psychobiol (2006) 1.56
Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol Clin Exp Res (2007) 1.53
Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques. Arch Gen Psychiatry (2007) 1.50
Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology (Berl) (1997) 1.49
The ability of the Self-Rating of the Effects of Alcohol (SRE) Scale to predict alcohol-related outcomes five years later. J Stud Alcohol Drugs (2007) 1.48
Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Subst Use Misuse (2010) 1.39
A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. Alcohol Clin Exp Res (2007) 1.33
Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry (2005) 1.29
Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet (2003) 1.29
Stimulant alcohol effects prime within session drinking behavior. Psychopharmacology (Berl) (2007) 1.28
Spousal concordance for alcohol dependence: evidence for assortative mating or spousal interaction effects? Alcohol Clin Exp Res (2007) 1.27
A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet (2003) 1.25
Genetic moderators of naltrexone's effects on alcohol cue reactivity. Alcohol Clin Exp Res (2006) 1.24
Approach to the genetics of alcoholism: a review based on pathophysiology. Biochem Pharmacol (2007) 1.24
Drinking expectancies and motives: a genetic study of young adult women. Addiction (2008) 1.21
Is risk for alcoholism mediated by individual differences in drinking motivations? Alcohol Clin Exp Res (2004) 1.14
Reliability of self-reported ancestry among siblings: implications for genetic association studies. Am J Epidemiol (2006) 1.14
Behavioral and physiological effects of ethanol in high-risk and control children: a pilot study. Alcohol Clin Exp Res (1983) 1.14
OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach. Alcohol Clin Exp Res (2008) 1.12
Mendelian randomization: a novel test of the gateway hypothesis and models of gene-environment interplay. Dev Psychopathol (2007) 1.11
Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. Alcohol Clin Exp Res (2004) 1.07
Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am J Med Genet (1999) 1.06
The role of self-defined race/ethnicity in population structure control. Ann Hum Genet (2006) 1.06
Association of functional opioid receptor genotypes with alcohol dependence in Koreans. Alcohol Clin Exp Res (2004) 1.06
Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am J Med Genet (2001) 1.05
The self-rating of the effects of alcohol questionnaire as a predictor of alcohol-related outcomes in 12-year-old subjects. Alcohol Alcohol (2008) 1.05
Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem Res (1996) 1.04
Association of candidate genes with antisocial drug dependence in adolescents. Drug Alcohol Depend (2008) 1.01
Association of mu-opioid receptor gene polymorphism A118G with alcohol dependence in a Japanese population. Neuropsychobiology (2006) 0.97
Can bipolar disorder-specific neuropsychological impairments in children be identified? J Consult Clin Psychol (2007) 0.96
Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals. Alcohol (2001) 0.96
Association between single nucleotide polymorphisms in the mu opioid receptor gene (OPRM1) and self-reported responses to alcohol in American Indians. BMC Med Genet (2008) 0.95
Genetic and environmental contributions to age of onset of alcohol dependence symptoms in male twins. Addiction (2004) 0.93
Lack of stimulant and anxiolytic-like effects of ethanol and accelerated development of ethanol dependence in mu-opioid receptor knockout mice. Neuropharmacology (2005) 0.89
Polymorphisms in the mu-opioid receptor gene (OPRM1) and the implications for alcohol dependence in humans. Pharmacogenomics (2007) 0.87
Electrophysiological assessment (The Multiple Sleep Latency Test) of the biphasic effects of ethanol in humans. Alcohol Clin Exp Res (1998) 0.87
Preliminary data on the association among the serotonin transporter polymorphism, subjective alcohol experiences, and drinking behavior. J Stud Alcohol (2006) 0.84
A randomized clinical trial of a brief motivational intervention for alcohol-positive adolescents treated in an emergency department. J Pediatr (2004) 3.62
Efficacy of counselor vs. computer-delivered intervention with mandated college students. Addict Behav (2007) 3.08
Population stratification in the candidate gene study: fatal threat or red herring? Psychol Bull (2004) 2.81
Validation of the timeline follow-back in the assessment of adolescent smoking. Drug Alcohol Depend (2005) 2.37
Genetic associations with intimate partner violence in a sample of hazardous drinking men in batterer intervention programs. Violence Against Women (2014) 2.31
Alcohol demand, delayed reward discounting, and craving in relation to drinking and alcohol use disorders. J Abnorm Psychol (2010) 2.27
Brief alcohol interventions with mandated or adjudicated college students. Alcohol Clin Exp Res (2004) 2.10
Frontal-limbic white matter pathway associations with the serotonin transporter gene promoter region (5-HTTLPR) polymorphism. J Neurosci (2009) 2.05
"I'll never drink like that again": characteristics of alcohol-related incidents and predictors of motivation to change in college students. J Stud Alcohol (2006) 1.87
Alcohol use disorders identification test: factor structure in an adolescent emergency department sample. Alcohol Clin Exp Res (2002) 1.85
Motivational enhancement and other brief interventions for adolescent substance abuse: foundations, applications and evaluations. Addiction (2004) 1.82
Motivational enhancement and coping skills training for cocaine abusers: effects on substance use outcomes. Addiction (2004) 1.68
Randomized clinical trial examining the incremental efficacy of a 90-minute motivational alcohol intervention as an adjunct to standard batterer intervention for men. Addiction (2013) 1.68
Stepped care for mandated college students: a pilot study. Am J Addict (2007) 1.58
Allelic variation in TAS2R bitter receptor genes associates with variation in sensations from and ingestive behaviors toward common bitter beverages in adults. Chem Senses (2010) 1.53
Sexual assault and alcohol use: exploring the self-medication hypothesis. Violence Vict (2002) 1.53
Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol Clin Exp Res (2007) 1.53
The Marijuana Ladder: measuring motivation to change marijuana use in incarcerated adolescents. Drug Alcohol Depend (2005) 1.53
Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcohol Clin Exp Res (2008) 1.51
Children's attentional biases and 5-HTTLPR genotype: potential mechanisms linking mother and child depression. J Clin Child Adolesc Psychol (2009) 1.49
Peer enhancement of a brief motivational intervention with mandated college students. Psychol Addict Behav (2007) 1.47
The mixed evidence for brief intervention in emergency departments, trauma care centers, and inpatient hospital settings: what should we do? Alcohol Clin Exp Res (2010) 1.47
Delay discounting, locus of control, and cognitive impulsiveness independently predict tobacco dependence treatment outcomes in a highly dependent, lower socioeconomic group of smokers. Am J Addict (2012) 1.45
Correlates of cigarette smoking during pregnancy and its genetic and environmental overlap with nicotine dependence. Nicotine Tob Res (2008) 1.45
Brief motivational intervention for adolescent smokers in medical settings. Addict Behav (2004) 1.44
CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Arch Gen Psychiatry (2007) 1.44
P-selectin 1087G/A polymorphism is associated with neuropsychological test performance in older adults with cardiovascular disease. Stroke (2009) 1.43
Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res (2008) 1.43
Predictors of motivation to change after medical treatment for drinking-related events in adolescents. Psychol Addict Behav (2002) 1.40
Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism. Subst Use Misuse (2010) 1.39
Polymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment. J Abnorm Psychol (2010) 1.37
Addressing alcohol use and problems in mandated college students: a randomized clinical trial using stepped care. J Consult Clin Psychol (2012) 1.36
Perceived barriers to quitting smoking among alcohol dependent patients in treatment. J Subst Abuse Treat (2003) 1.36
The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology (2006) 1.34
Behavioral economic analysis of cue-elicited craving for alcohol. Addiction (2010) 1.33
Addressing heavy drinking in smoking cessation treatment: a randomized clinical trial. J Consult Clin Psychol (2008) 1.33
Olanzapine reduces craving for alcohol: a DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology (2003) 1.29
Enhancing Substance Abuse Treatment Engagement in Incarcerated Adolescents. Psychol Serv (2006) 1.27
Treating adolescents together or individually? Issues in adolescent substance abuse interventions. Alcohol Clin Exp Res (2002) 1.26
The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychol (2002) 1.26
Limitations of DSM-IV operationalizations of alcohol abuse and dependence in a sample of Australian twins. Twin Res Hum Genet (2005) 1.26
Profiles of college students mandated to alcohol intervention. J Stud Alcohol Drugs (2008) 1.25
Moderators and mediators of two brief interventions for alcohol in the emergency department. Addiction (2010) 1.24
Genetic moderators of naltrexone's effects on alcohol cue reactivity. Alcohol Clin Exp Res (2006) 1.24
Individual and family motivational interventions for alcohol-positive adolescents treated in an emergency department: results of a randomized clinical trial. Arch Pediatr Adolesc Med (2011) 1.24
Quantitative trait locus for reading disability on chromosome 6p is pleiotropic for attention-deficit/hyperactivity disorder. Am J Med Genet (2002) 1.22
Correlates of motivation to quit smoking among alcohol dependent patients in residential treatment. Drug Alcohol Depend (2005) 1.21
Response distortion in adolescents who smoke: a pilot study. J Drug Educ (2002) 1.21
Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) (2012) 1.21
The route to change: within-session predictors of change plan completion in a motivational interview. J Subst Abuse Treat (2010) 1.18
Alcoholism: the dissection for endophenotypes. Dialogues Clin Neurosci (2005) 1.16
Cost-effectiveness of a motivational intervention for alcohol-involved youth in a hospital emergency department. J Stud Alcohol Drugs (2010) 1.16
Cue reactivity in adolescents: measurement of separate approach and avoidance reactions. J Stud Alcohol (2005) 1.14
The dopamine D Receptor (DRD4) gene exon III polymorphism, problematic alcohol use and novelty seeking: direct and mediated genetic effects. Addict Biol (2008) 1.14
Accuracy of mothers' retrospective reports of smoking during pregnancy: comparison with twin sister informant ratings. Twin Res (2003) 1.13
Cocaine craving as a predictor of treatment attrition and outcomes after residential treatment for cocaine dependence. J Stud Alcohol Drugs (2007) 1.12
Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity. Alcohol Clin Exp Res (2012) 1.12
Daily college student drinking patterns across the first year of college. J Stud Alcohol Drugs (2012) 1.10
The alcohol hangover research group consensus statement on best practice in alcohol hangover research. Curr Drug Abuse Rev (2010) 1.09
The commitment to quitting smoking scale: initial validation in a smoking cessation trial for heavy social drinkers. Addict Behav (2007) 1.09
Acute Effects of Marijuana Smoking on Negative and Positive Affect. J Cogn Psychother (2011) 1.08
High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Exp Clin Psychopharmacol (2007) 1.07
The Smoking Effects Questionnaire for adult populations. Development and psychometric properties. Addict Behav (2003) 1.07
The role of marijuana use in brief motivational intervention with young adult drinkers treated in an emergency department. J Stud Alcohol Drugs (2009) 1.07
Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol (2009) 1.05
Motivational interviewing for incarcerated adolescents: effects of depressive symptoms on reducing alcohol and marijuana use after release. J Stud Alcohol Drugs (2011) 1.05
Alcohol use and related harm among older adolescents treated in an emergency department: the importance of alcohol status and college status. J Stud Alcohol (2003) 1.04
Nicotine and other substance interaction expectancies questionnaire: relationship of expectancies to substance use. Addict Behav (2005) 1.04
Sensation seeking as a predictor of treatment compliance and smoking cessation treatment outcomes in heavy social drinkers. Pharmacol Biochem Behav (2009) 1.04
Effects of motivational interviewing for incarcerated adolescents on driving under the influence after release. Am J Addict (2006) 1.03
Motivational interviewing with significant other participation: assessing therapeutic alliance and patient satisfaction and engagement. J Subst Abuse Treat (2010) 1.02
Bitterness of the non-nutritive sweetener acesulfame potassium varies with polymorphisms in TAS2R9 and TAS2R31. Chem Senses (2013) 1.02
Urge-specific and lifestyle coping strategies of cocaine abusers: relationships to treatment outcomes. Drug Alcohol Depend (2005) 1.02
Effect of a significant other on client change talk in motivational interviewing. J Consult Clin Psychol (2012) 1.02
Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial. Addict Biol (2013) 1.02
Examining the role of common genetic variants on alcohol, tobacco, cannabis and illicit drug dependence: genetics of vulnerability to drug dependence. Addiction (2015) 1.01
Contingency management and motivational enhancement: a randomized clinical trial for college student smokers. Nicotine Tob Res (2009) 1.01
Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence. Psychol Addict Behav (2004) 1.00
Children's inferential styles, 5-HTTLPR genotype, and maternal expressed emotion-criticism: An integrated model for the intergenerational transmission of depression. J Abnorm Psychol (2009) 1.00
Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacol Biochem Behav (2009) 1.00
Naltrexone treatment for alcoholics: effect on cigarette smoking rates. Nicotine Tob Res (2003) 1.00
Risk factors for alcohol misuse: examining heart rate reactivity to alcohol, alcohol sensitivity, and personality constructs. Addict Behav (2006) 1.00
The interpretability of family history reports of alcoholism in general community samples: findings in a midwestern U.S. twin birth cohort. Alcohol Clin Exp Res (2012) 1.00
Effects of repeated days of smoking cue exposure on urge to smoke and physiological reactivity. Addict Behav (2007) 0.99
Pharmacological effects of naltrexone and intravenous alcohol on craving for cigarettes among light smokers: a pilot study. Psychopharmacology (Berl) (2007) 0.98
Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence. Addict Behav (2010) 0.98
A preliminary pharmacogenetic investigation of adverse events from topiramate in heavy drinkers. Exp Clin Psychopharmacol (2009) 0.98
Co-Occurring Sexual Risk and Substance Use Behaviors Among Incarcerated Adolescents. J Correct Health Care (2006) 0.97
The Cocaine Effects Questionnaire for patient populations: development and psychometric properties. Addict Behav (2004) 0.95
Altered emotion-modulated startle in young adults with a family history of alcoholism. Alcohol Clin Exp Res (2002) 0.95
Hostility, cigarette smoking, and responses to a lab-based social stressor. Exp Clin Psychopharmacol (2009) 0.95
Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics. Exp Clin Psychopharmacol (2007) 0.95
Daily associations between alcohol use and unprotected anal sex among heavy drinking HIV-positive men who have sex with men. AIDS Behav (2015) 0.95